Table 2 Summary of iron associated miRNAs in cancer.
From: Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression
Name | Associated cancer type | Target | Influence to iron | Model of evidence | Reference |
---|---|---|---|---|---|
miR-150 | Hepatocellular carcinoma | FPN | Up | Cell culture | |
miR-17-5p | Multiple myeloma | FPN | Up | Cell culture, animal models | |
miR-20a | Lung cancer | FPN | Up | Cell culture | |
miR-492 | Prostate cancer | FPN | Up | Cell culture, animal models | |
miR-194 | Colorectal cancer | TFR1, FPN1 | Up | Clinical samples | |
miR-449a | Glioma | CDGSH iron sulfur domain 2 | Down | Cell culture, animal models | |
miR-149 | Colorectal cancer | DMT1 | Down | Clinical samples | |
miR-19a | Colorectal cancer | DMT1 | Down | Clinical samples | |
miR-181a-5p | Prostate cancer | FHC | Down | Cell culture, animal models | |
miR-19b-1-5p | Prostate cancer | FHC | Down | Cell culture, animal models | |
miR-19b-3p | Prostate cancer | FHC | Down | Cell culture, animal models | |
miR-210-3p | Prostate cancer | FHC | Down | Cell culture, animal models | |
miR-362-5p | Prostate cancer | FHC | Down | Cell culture, animal models | |
miR-616-3p | Prostate cancer | FHC | Down | Cell culture, animal models | |
miR-638 | Prostate cancer | FHC | Down | Cell culture, animal models | |
miR-200b | Hepatocellular carcinoma, breast cancer | Ferritin | Down | Cell culture | |
miR-133a | Colorectal cancer, breast cancer | FLC | Down | Cell culture | |
miR-29 | Lung cancer | Iron-responsive element binding protein 2 | Down | Clinical samples | |
miR-210 | Renal cancer, head and neck paragangliomas, breast cancer, colorectal cancer, and oropharyngeal squamous cell carcinomas | ISCU, TFR1 | Down | Cell culture, animal models | |
miR-126 | Malignant mesothelioma | Mitochondria-destabilizing stress signals | Down | Cell culture, animal models | |
miR-7-5p | Ovarian cancer, colorectal cancer | Mitoferrin | Down | Cell culture | |
miR-122 | Hepatocellular cancer | Nocturnin | Down | Cell culture, animal models | |
miR-34a | Lung cancer | P53 | Down | Cell culture, animal models | |
miR-141 | Colorectal cancer | TFR1 | Down | Clinical samples | |
miR-145 | Colorectal cancer | TFR1 | Down | Clinical samples | |
miR-152 | Hepatocellular carcinoma | TFR1 | Down | Cell culture, animal models | |
miR-182 | Colorectal cancer | TFR1 | Down | Clinical samples | |
miR-200a | Hepatocellular carcinoma | TFR1 | Down | Cell culture | |
miR-22 | Hepatocellular cancer | TFR1 | Down | Cell culture | |
miR-31 | Colorectal cancer | TFR1 | Down | Clinical samples | |
miR-320 | Hepatocellular cancer | TFR1 | Down | Cell culture | |
miR-758 | Colorectal cancer | TFR1 | Down | Clinical samples | |
miR-107 | Hepatocellular carcinoma | – | Inhibited by iron | Cell culture, animal models | |
miR-125b | Ovarian cancer | – | Inhibited by iron | Cell culture | |
miR-30d | Hepatocellular carcinoma | – | Inhibited by iron | Cell culture, animal models | |
miR-146a | Ovarian cancer | – | Induced by iron | Cell culture | |
miR-150 | Ovarian cancer | – | Induced by iron | Cell culture | |
miR-214-3p | Neuroblastoma | – | Induced by iron | Cell culture | |
miR-584 | Neuroblastoma | – | Induced by iron | Cell culture |